ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease - Wikidata - awgldk - TriplyDB

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease

http://www.wikidata.org/entity/Q57269407

about

Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome Recent Advances in Kawasaki Disease Mercury promotes catecholamines which potentiate mercurial autoimmunity and vasodilation: implications for inositol 1,4,5-triphosphate 3-kinase C susceptibility in kawasaki syndrome Can Coronary Artery Involvement in Kawasaki Disease be Predicted?Understanding the pathogenesis of Kawasaki disease by network and pathway analysis Meta-analysis of the relationship between single nucleotide polymorphism rs72689236 of caspase-3 and Kawasaki disease.The roles of Ca2+/NFAT signaling genes in Kawasaki disease: single- and multiple-risk genetic variants.Update of genetic susceptibility in patients with Kawasaki disease.A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease Gene-Gene Associations with the Susceptibility of Kawasaki Disease and Coronary Artery Lesions.Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease A child with resistant Kawasaki disease successfully treated with anakinra: a case report.Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease.Management of Kawasaki disease.A combination of cross correlation and trend analyses reveals that Kawasaki disease is a pollen-induced delayed-type hyper-sensitivity disease.A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.Kawasaki disease: insights into pathogenesis and approaches to treatment.Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective.Identification of Differentially Expressed Genes in Kawasaki Disease Patients as Potential Biomarkers for IVIG Sensitivity by Bioinformatics Analysis.Dissecting Kawasaki disease: a state-of-the-art review.ITPKC and SLC11A1 Gene Polymorphisms and Gene-Gene Interactions in Korean Patients with Kawasaki Disease.One Size Does Not Fit All: Genetic Prediction of Kawasaki Disease Treatment Response in Diverse Populations.The genetics of Kawasaki disease.Innate immune responses following Kawasaki disease and toxic shock syndrome.

P2860

Q26765479-B0AE3E5E-9C6A-4727-85AE-2674799EB0AA Q26775248-AED1521F-8644-41A7-B859-CB609E0DDBD5 Q26824143-116DCED6-F927-41E9-830B-2348B967816F Q26829091-76CA30FA-C2ED-46AA-AF62-227AF96734A1 Q26996702-7ECEFEDF-C9AA-4BDC-A777-F334404654F9 Q31171024-42A6C8CE-C852-40CA-8B1A-35AA5B4C2A08 Q33718942-E19B0C2C-AD33-4CD5-9B47-43F2BE170D5B Q34043722-A10E50E2-7421-4A15-8EA1-D222FF3D016F Q34874251-67F67293-0E10-404F-80D5-FAE44E7C6355 Q35855926-6F15127A-D81E-4C70-9199-278609F1C43A Q36015444-72408ACF-D537-4976-B726-19D0BDA34851 Q36340938-A3D4A3A8-6FE3-4E9E-97ED-A80157E3EFEA Q36374231-E607DEF5-DE28-49DE-9D93-41E55AA6B4FF Q36731339-61306BC9-CCB0-46FF-9CF2-B450C532B69E Q37465500-F9FD1C96-C585-49D1-A8CC-E449F96EC4A0 Q37703211-7FC1E10E-3FA2-40A1-9CD4-96765792C02C Q38322444-60D0D002-2913-4B01-A46E-515DE2488CBF Q38439648-9DEB2B90-A411-4A3F-B6E3-9038A985C7FE Q38719434-74EBCA11-B6C2-45C1-A177-DCF154056802 Q38869612-C0AE53FD-E792-4A6D-9320-B4185E9882EA Q39401720-DD08AC32-4B01-49F8-A0A9-D97371FECD7B Q47108668-FC9B42CB-5ECD-46BE-9CE7-AE335C47EB7D Q47182586-0C461580-14B6-4295-B904-1CBF48B2A5FE Q49892043-ABAB20B0-A34D-4811-9A30-38EE4221C786 Q49980459-229C6D8E-D78A-43E9-A059-C96802804B3F

P2860

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease

http://www.wikidata.org/entity/Q57269407

description

im Oktober 2011 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2011

@uk

name

ITPKC and CASP3 polymorphisms ...... formation in Kawasaki disease

@en

ITPKC and CASP3 polymorphisms ...... formation in Kawasaki disease

@nl

type

label

ITPKC and CASP3 polymorphisms ...... formation in Kawasaki disease

@en

ITPKC and CASP3 polymorphisms ...... formation in Kawasaki disease

@nl

prefLabel

ITPKC and CASP3 polymorphisms ...... formation in Kawasaki disease

@en

ITPKC and CASP3 polymorphisms ...... formation in Kawasaki disease

@nl

P1433

Q57269407-8228880E-B839-4F94-A728-03AEDDF659BA

P1476

Q57269407-51AB8714-059B-4AC5-9B93-EDC45121B80E

P2093

Q57269407-06A84CCA-EA5D-4DF6-B53E-8EE2CE051FCE

Q57269407-18775F3D-1F73-48FF-A3F8-16A17BE1D43B

Q57269407-1A212573-96F3-4929-A3DA-D83E0304F3FD

Q57269407-278597B0-3A37-4AFF-900F-29E6149599F6

Q57269407-2C636312-1BE0-4EEC-A14E-B46C5EEB0E7D

Q57269407-3200D401-B219-4A09-8C9A-546DF1C77FD8

Q57269407-4B5A1FEC-EA2A-485C-9D23-7545E3D07BF0

Q57269407-513D6CBB-C357-4539-ACA3-853459E86486

Q57269407-71CB0046-5615-410C-AC05-104548161BE3

Q57269407-817739F9-80BD-4EA3-A7F3-3AC77BC259DB

P2860

Q57269407-029733B8-8C8C-4A33-8FA6-ABB90E269592

Q57269407-115F423F-23CC-46C4-92F5-EEAADB59DF65

Q57269407-17376BCB-AABB-48BB-85CE-E84F589BA5B8

Q57269407-2EEA135E-4495-41E8-B2D6-2C7B625D1CBD

Q57269407-4198FCCE-DF34-4D60-ADEF-82930538B214

Q57269407-42F01182-0344-400F-A4DB-DC164CF3CE57

Q57269407-6ABF44FD-1552-4106-BA15-BCDF2C2EC247

Q57269407-8BDDCCF1-99F4-4D20-8A1A-3577B57470CD

Q57269407-9907D17D-F946-4135-9BA0-FD9BA3BA3A7D

Q57269407-997F0B7A-FE7B-41A8-91EB-CD0F633A0613

P2888

Q57269407-F6FA36DA-9254-429C-BA06-419B035F5ED3

P304

Q57269407-31F4CA08-155F-49ED-85F5-5BEB620365FB

P31

Q57269407-D4A61EA8-303B-463D-9AC3-83C0512D5199

P356

Q57269407-D98E30DE-5233-45B3-B85C-F8E3A29ABD4D

P433

Q57269407-4B6DD752-F1D3-4646-B0C8-C134C37BB931

P478

Q57269407-77E801FF-727B-4C5D-865F-F8A9138575DB

P50

Q57269407-3625396E-32EC-4D7A-A548-EB466CCEBAE9

Q57269407-920353D7-17BC-419B-897B-7742F3086F3A

Q57269407-E1278764-F5D1-4044-882F-66406564E3CF

P577

Q57269407-DE48DE71-98D6-4BD7-952F-BB66AAA1D15D

P698

Q57269407-A4CDE04E-9B53-4E1C-BA7B-A0DD6B305E24

P356

P1433

The Pharmacogenomics Journal

P1476

ITPKC and CASP3 polymorphisms ...... formation in Kawasaki disease

@en

P2093

A Honda

http://www.w3.org/2001/XMLSchema#string

H Hamada

http://www.w3.org/2001/XMLSchema#string

H Kobayashi

http://www.w3.org/2001/XMLSchema#string

H Suzuki

http://www.w3.org/2001/XMLSchema#string

H Yamaga

http://www.w3.org/2001/XMLSchema#string

J Sato

http://www.w3.org/2001/XMLSchema#string

K Higashi

http://www.w3.org/2001/XMLSchema#string

K Oishi

http://www.w3.org/2001/XMLSchema#string

K Sasago

http://www.w3.org/2001/XMLSchema#string

K Yasukawa

http://www.w3.org/2001/XMLSchema#string

P2860

ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population.

Common variants in CASP3 confer susceptibility to Kawasaki disease.

A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.

Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin.

Molecular genetics of Kawasaki disease.

Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome.

Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.

Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3.

P2888

P304

52-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/TPJ.2011.45

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Toshihiro Tanaka

P577

2011-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21987091

http://www.w3.org/2001/XMLSchema#string